Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

被引：0

作者：

Pierce, J. B. ^{[1
]}

Vaduganathan, M. ^{[2
]}

Fonarow, G. C. ^{[3
]}

Ikeaba, U. ^{[4
]}

Chiswell, K. ^{[4
]}

Huang, J. ^{[5
]}

Linganathan, K. ^{[5
]}

Mcdermott, J. ^{[5
]}

Greene, S. J. Stephen ^{[4
]}

机构：

[1] Duke Univ, Sch Med, Durham, NC 27706 USA

[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[4] Duke Clin Res Inst, Durham, NC USA

[5] AstraZeneca, Wilmington, DE USA

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：66 / 67

页数：2

共 50 条

[1] CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY
Alcidi, G.
Pugliese, R.
Ioannoni, S.
Romano, M.
Granatiero, M.
Diomede, D.
Benvenuto, M.
Correale, M.
Brunetti, N.
Gronda, E.
Iacoviello, M.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
[2] SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
Sanchez Gonzalez, V. Virtudes
Flano-Lombardo, R.
Esteve-Ruiz, I.
Cortez, G.
Aranda-Dios, A.
Duran-Torralba, C.
Rangel-Sousa, D.
Sobrino-Marquez, J. M.
Grande-Trillo, A.
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 72 - 73
[3] SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this
Soh, B. W. T.
Balfe, C.
O'Brien, K.
Glasgow, J.
Forkin, A.
Sim, W. H.
Muradagha, H.
Abbas, S.
Arnous, S.
Kiernan, T.
EUROPEAN HEART JOURNAL, 2022, 43 : 952 - 952
[4] ECHOCARDIOGRAPHIC FINDING BETWEEN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION IN TREATMENT WITH ARNI AND SGLT2I
Ceci, Vincenzo
Mazzeo, Pietro
Ferrara, Salvatore
Nardella, Luigi
Tricarico, Lucia
Alfieri, Simona
Croella, Francesca
Amatruda, Marco
Granatiero, Michele
D'alessandro, Damiano
Di Nunno, Nicola
Pugliese, Rosanna
Noviello, Giulia
Correale, Michele
Stabile, Egenio
Stabile, Eugenio
Iacoviello, Massimo
Di Biase, Matteo
Brunetti, Natale D.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
[5] Risk of genitourinary infection similar among SGLT2i in patients with heart failure and preserved ejection fraction
Reactions Weekly, 2024, 2011 (1) : 10 - 10
[6] UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION
Pugliese, R.
Alcidi, G.
Ioannoni, S.
Diomede, D.
Romano, M.
Correale, M.
Benvenuto, M.
Gronda, E.
Brunetti, N.
Iacoviello, M.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
[7] UTILIZATION OF SGLT2 INHIBITORS IN UNITED STATES VETERANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
Chiu, Leonard
Park, Daniel
Gupta, Deepak K.
Matheny, Michael Edwin
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 286 - 286
[8] SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta-analysis
Yan, Yuling
Liu, Bin
Du, Jun
Wang, Jing
Jing, Xiaodong
Liu, Yajie
Deng, Songbai
Du, Jianlin
She, Qiang
ESC HEART FAILURE, 2021, 8 (03): : 2210 - 2219
[9] SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction
Nuzzi, Vincenzo
Manca, Paolo
Parisi, Francesca
Madaudo, Cristina
Sciacca, Sergio
Cannizzo, Noemi
Mule, Massimiliano
Cipriani, Manlio G.
CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (11)
[10] Baseline characteristics and alterations after initiation of therapy with SGLT2i in a real-world heart failure with reduced ejection fraction population
Stavrati, A.
Polymeropoulos, K.
Ioannidis, P.
Kleitsioti, P.
Lazaridis, P.
Zarifis, J.
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 163 - 163

← 1 2 3 4 5 →